Evaluating Tibolone Add-back in Patients With Endometriosis and Fibroids

Stopped More critical projects were prioritized.

Conditions

• Endometriosis
• Fibroids

Interventions

• DRUG: Tibolone 2.5 Mg Oral Tablet

Sponsor

McGill University Health Centre/Research Institute of the McGill University Health Centre